Daniel M. Halperin, MD

Daniel M. Halperin, MD,is an associate professor and vice chair for clinical affairs in the Department of Hematology and Medical Oncology at Winship Cancer Institute of Emory University. Dr Halperin earned his medical degree from Weill Cornell Medical College. He completed his fellowship training in medical oncology at The University of Texas MD Anderson Cancer Center and his residency in internal medicine at Brigham and Women's Hospital. He was recruited to Winship in 2024 from MD Anderson Cancer Center, where he was chair of the Neuroendocrine Tumor Multidisciplinary Conference (Tumor Board) and clinical medical director of the Gastrointestinal Center.

Dr Halperin is board certified in medical oncology and internal medicine and is a clinical investigator primarily focused on the development of novel treatments for patients with neuroendocrine tumors (NETs). As a clinical investigator, he leads clinical trials of new drugs for patients with NETs, and he works with a team of laboratory and population scientists to understand more fully the molecular underpinnings and clinical manifestations of NETs.

He serves on the Neuroendocrine Tumor Research Foundation Board of Scientific Advisors, the Healing NET Foundation Scientific Advisory Committee, and the North American Neuroendocrine Tumor Society (NANETS) Board of Directors. He is also past chair of the NANETS Scientific Review & Research Committee and a prior member of the National Comprehensive Cancer Network (NCCN) Neuroendocrine and Adrenal Tumors Guideline Committee.